Expression profile of plasma microRNAs and target genes in patients with complicated pregnancy

M. D. Umerova, S. S. Alyadinova, M. J. Khonjonova, R. A. Balakadasheva, E. E. Menadzhiev, D. I. Kharchuk, D. O. Leus, G. I. Islyamova, M. I. Islyamova, S. L. Abkarimova, D. S. Kasabyan, L. Sorokina
{"title":"Expression profile of plasma microRNAs and target genes in patients with complicated pregnancy","authors":"M. D. Umerova, S. S. Alyadinova, M. J. Khonjonova, R. A. Balakadasheva, E. E. Menadzhiev, D. I. Kharchuk, D. O. Leus, G. I. Islyamova, M. I. Islyamova, S. L. Abkarimova, D. S. Kasabyan, L. Sorokina","doi":"10.17749/2313-7347/ob.gyn.rep.2023.420","DOIUrl":null,"url":null,"abstract":"Aim: to assess features of placental transcriptome in patients with complicated pregnancy course and outcome.Materials and Methods. A prospective observational comparative study in parallel groups was carried out by examining 44 patients divided into three groups: group 1 included 13 pregnant women with moderate and severe preeclampsia (PE), group 2 consisted of 12 patients with fetal growth retardation (FGR), control group included 19 clinically healthy women with uncomplicated pregnancy and delivery. All women enrolled to the study underwent a comprehensive examination, including history collection, general and obstetric-gynecological examination, laboratory and instrumental studies. Special research methods were used during the study, which included placental tissue sampling followed by analyzed expression profile of 12 microRNAs using real-time polymerase chain reaction (PCR).Results. The PCR data indicated about lack of expression for analyzed miR-210-3p, miR-320-3p, miR-1304-5p and miR-375-5p in placental tissue samples in FGR patients. No significant differences in placental miRNA levels were observed in FGR vs. PE and control group. Analysis of placenta-specific microRNAs in women with PE vs. control group showed a significantly down modulated expression level for miR-517a-3p (p = 0.025), miR-517c-3p (p = 0.036), miR-574-5p (p = 0.015) along with upregulated expression of miR-20a-5p (p = 0.046).Conclusion. The data obtained evidence that pregnancy-related complications are characterized by specific molecular changes at placental transcriptome level.","PeriodicalId":36521,"journal":{"name":"Obstetrics, Gynecology and Reproduction","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics, Gynecology and Reproduction","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.420","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: to assess features of placental transcriptome in patients with complicated pregnancy course and outcome.Materials and Methods. A prospective observational comparative study in parallel groups was carried out by examining 44 patients divided into three groups: group 1 included 13 pregnant women with moderate and severe preeclampsia (PE), group 2 consisted of 12 patients with fetal growth retardation (FGR), control group included 19 clinically healthy women with uncomplicated pregnancy and delivery. All women enrolled to the study underwent a comprehensive examination, including history collection, general and obstetric-gynecological examination, laboratory and instrumental studies. Special research methods were used during the study, which included placental tissue sampling followed by analyzed expression profile of 12 microRNAs using real-time polymerase chain reaction (PCR).Results. The PCR data indicated about lack of expression for analyzed miR-210-3p, miR-320-3p, miR-1304-5p and miR-375-5p in placental tissue samples in FGR patients. No significant differences in placental miRNA levels were observed in FGR vs. PE and control group. Analysis of placenta-specific microRNAs in women with PE vs. control group showed a significantly down modulated expression level for miR-517a-3p (p = 0.025), miR-517c-3p (p = 0.036), miR-574-5p (p = 0.015) along with upregulated expression of miR-20a-5p (p = 0.046).Conclusion. The data obtained evidence that pregnancy-related complications are characterized by specific molecular changes at placental transcriptome level.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
复杂妊娠患者血浆microrna及靶基因表达谱分析
目的:探讨复杂妊娠过程及结局患者胎盘转录组特征。材料与方法。采用平行组前瞻性观察比较研究,将44例患者分为3组:1组13例中重度先兆子痫(PE)孕妇,2组12例胎儿生长迟缓(FGR)孕妇,对照组19例临床健康无并发症妊娠分娩妇女。所有参加研究的妇女都接受了全面的检查,包括病史收集、普通和妇产科检查、实验室和仪器检查。在研究过程中采用了特殊的研究方法,包括胎盘组织取样,然后使用实时聚合酶链反应(PCR)分析12个microrna的表达谱。PCR数据显示,分析的miR-210-3p、miR-320-3p、miR-1304-5p和miR-375-5p在FGR患者胎盘组织样本中缺乏表达。FGR组与PE组和对照组相比,胎盘miRNA水平无显著差异。与对照组相比,PE女性胎盘特异性microrna的分析显示,miR-517a-3p (p = 0.025)、miR-517c-3p (p = 0.036)、miR-574-5p (p = 0.015)的表达水平显著下调,miR-20a-5p的表达水平上调(p = 0.046)。这些数据证明妊娠相关并发症与胎盘转录组水平的特异性分子变化有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
68
审稿时长
12 weeks
期刊最新文献
Immunological testing for female infertility: a modern view on the problem Septic shock in obstetrics: the role of efferent techniques for endotoxin removal in Gram-negative sepsis Surfactant lung lavage in neonatal meconium aspiration syndrome as a life-saving respiratory strategy: literature review and a case report Maternal death in world literature Primary hyperparathyroidism in pregnancy after in vitro fertilization
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1